BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 1610409)

  • 1. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde.
    Dockham PA; Lee MO; Sladek NE
    Biochem Pharmacol; 1992 Jun; 43(11):2453-69. PubMed ID: 1610409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the mouse aldehyde dehydrogenases important in aldophosphamide detoxification.
    Manthey CL; Landkamer GJ; Sladek NE
    Cancer Res; 1990 Aug; 50(16):4991-5002. PubMed ID: 2379164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contribution of human erythrocyte aldehyde dehydrogenase to the systemic detoxification of the oxazaphosphorines.
    Dockham PA; Sreerama L; Sladek NE
    Drug Metab Dispos; 1997 Dec; 25(12):1436-41. PubMed ID: 9394035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic characterization of the catalysis of "activated" cyclophosphamide (4-hydroxycyclophosphamide/aldophosphamide) oxidation to carboxyphosphamide by mouse hepatic aldehyde dehydrogenases.
    Manthey CL; Sladek NE
    Biochem Pharmacol; 1988 Jul; 37(14):2781-90. PubMed ID: 3395357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid.
    Lee MO; Manthey CL; Sladek NE
    Biochem Pharmacol; 1991 Aug; 42(6):1279-85. PubMed ID: 1888336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes.
    von Eitzen U; Meier-Tackmann D; Agarwal DP; Goedde HW
    Cancer Lett; 1994 Jan; 76(1):45-9. PubMed ID: 8124665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamide.
    Maki PA; Sladek NE
    Biochem Pharmacol; 1993 Jan; 45(1):231-9. PubMed ID: 8424816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide.
    Parekh HK; Sladek NE
    Biochem Pharmacol; 1993 Sep; 46(6):1043-52. PubMed ID: 8216347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3.
    Giorgianni F; Bridson PK; Sorrentino BP; Pohl J; Blakley RL
    Biochem Pharmacol; 2000 Aug; 60(3):325-38. PubMed ID: 10856427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
    Klyosov AA
    Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human brain glyceraldehyde-3-phosphate dehydrogenase, succinic semialdehyde dehydrogenase and aldehyde dehydrogenase isozymes: substrate specificity and sensitivity to disulfiram.
    Ryzlak MT; Pietruszko R
    Alcohol Clin Exp Res; 1989 Dec; 13(6):755-61. PubMed ID: 2690658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism.
    Klyosov AA; Rashkovetsky LG; Tahir MK; Keung WM
    Biochemistry; 1996 Apr; 35(14):4445-56. PubMed ID: 8605194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase.
    Rekha GK; Sreerama L; Sladek NE
    Biochem Pharmacol; 1994 Nov; 48(10):1943-52. PubMed ID: 7986206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative Biotransformation of Retinal to Retinoic Acid or Retinol by an Aldehyde Dehydrogenase from Bacillus cereus.
    Hong SH; Ngo HP; Nam HK; Kim KR; Kang LW; Oh DK
    Appl Environ Microbiol; 2016 Jul; 82(13):3940-3946. PubMed ID: 27107124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplicity and identity of human aldehyde dehydrogenases.
    Pietruszko R; Ryzlak MT; Forte-McRobbie CM
    Alcohol Alcohol Suppl; 1987; 1():175-9. PubMed ID: 3426676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A).
    Murphy TC; Amarnath V; Gibson KM; Picklo MJ
    J Neurochem; 2003 Jul; 86(2):298-305. PubMed ID: 12871571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human brain "high Km" aldehyde dehydrogenase: purification, characterization, and identification as NAD+ -dependent succinic semialdehyde dehydrogenase.
    Ryzlak MT; Pietruszko R
    Arch Biochem Biophys; 1988 Nov; 266(2):386-96. PubMed ID: 3190233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant class I aldehyde dehydrogenases specific for all-trans- or 9-cis-retinal.
    Montplaisir V; Lan NC; Guimond J; Savineau C; Bhat PV; Mader S
    J Biol Chem; 2002 May; 277(20):17486-92. PubMed ID: 11882655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
    Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
    Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.